亚洲人群的肥胖与代谢健康:新加坡基于双能X线吸收法的流行病学研究
新加坡HELIOS多族裔队列纳入9067名30-84岁亚洲成人,用双能X线吸收法评估体成分,横断面分析BMI与内脏脂肪质量指数(vFMI)与糖脂代谢、血压及代谢综合征评分的关系。马来与印度裔肥胖及2型糖尿病风险约为华裔的3-4倍;vFMI可解释族裔间甘油三酯和血压差异,但未解释印度裔血糖更高、胰岛素敏感性更低及2型糖尿病风险更高。
要点
- 马来与印度裔参与者肥胖和2型糖尿病风险约为华裔的3-4倍。
- 内脏脂肪质量指数可解释亚裔族裔间甘油三酯和血压的差异。
- 内脏脂肪质量指数未解释印度裔血糖更高及2型糖尿病风险更高。
核心结论
- 内脏肥胖是亚洲人群代谢病的独立危险因素,在各族裔中可解释很大一部分2型糖尿病病例,但族裔间胰岛素抵抗和2型糖尿病风险差异未被肥胖一致解释,提示存在其他机制。
研究设计与样本
- HELIOS研究为基于新加坡多族裔亚洲男女人群的队列,年龄30-84岁,本研究为横断面分析,纳入完成双能X线吸收法体成分评估和代谢特征分析者9067人。
- 在未使用2型糖尿病、高血压和高胆固醇血症药物的参与者亚组中,用多变量回归分析BMI和内脏脂肪质量指数(vFMI)与心血管代谢表型、疾病结局及代谢综合征评分的关系。
主要发现
- 2018年4月2日至2022年1月28日共10004人同意加入HELIOS队列,9067人被纳入研究:女性5404人(59.6%)、男性3663人(40.4%);华裔6224人(68.6%)、马来裔1169人(12.9%)、印度裔1674人(18.5%);平均年龄52.8岁(SD 11.8)。
- 2型糖尿病、高胆固醇血症和高血压患病率分别为8.2%(n=744)、27.2%(n=2469)和18.0%(n=1630)。
- 与华裔相比,马来裔和印度裔参与者肥胖和2型糖尿病的比值比为3-4倍,并表现出不利的代谢和肥胖特征。
- 过度肥胖与不良心血管代谢健康指标相关,包括2型糖尿病(p<0.0001)。
- vFMI解释了亚裔族裔间甘油三酯和血压的差异,但未解释印度裔参与者血糖升高、胰岛素敏感性降低及2型糖尿病风险增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 diabetes, cardiovascular disease, and related cardiometabolic disturbances are increasing rapidly in the Asia-Pacific region. We investigated the contribution of excess adiposity, a key determinant of type 2 diabetes and cardiovascular risk, to unfavourable cardiometabolic profiles among Asian ethnic subgroups. METHODS: The Health for Life in Singapore (HELIOS) Study is a population-based cohort comprising multiethnic Asian men and women living in Singapore, aged 30-84 years. We performed a cross-sectional analysis of data from individuals who had assessment of body composition by dual-energy x-ray absorptiometry and metabolic characterisation. In a subset of participants on no medication for type 2 diabetes, hypertension, and hypercholesterolaemia, we tested the relationship of BMI and visceral fat mass index (vFMI) with cardiometabolic phenotypes (glycaemic indices, lipid levels, and blood pressure), disease outcomes (type 2 diabetes, hypercholesterolaemia, and hypertension), and metabolic syndrome score with multivariable regression analyses. FINDINGS: Between April 2, 2018, and Jan 28, 2022, 10 004 individuals consented to be part of the HELIOS cohort, of whom 9067 were included in the study (5404 [59·6%] female, 3663 [40·4%] male; 6224 [68·6%] Chinese, 1169 [12·9%] Malay, 1674 [18·5%] Indian; mean age 52·8 years [SD 11·8]). The prevalence of type 2 diabetes, hypercholesterolaemia, and hypertension was 8·2% (n=744), 27·2% (n=2469), and 18·0% (n=1630), respectively. Malay and Indian participants had 3-4-times higher odds of obesity and type 2 diabetes, and showed adverse metabolic and adiposity profiles, compared with Chinese participants. Excess adiposity was associated with adverse cardiometabolic health indices including type 2 diabetes (p<0·0001). However, while vFMI explained the differences in triglycerides and blood pressure between the Asian ethnic groups, increased vFMI did not explain higher glucose levels, reduced insulin sensitivity, and increased risk of type 2 diabetes among Indian participants. INTERPRETATION: Visceral adiposity is an independent risk factor for metabolic disease in Asian populations, and accounts for a large fraction of type 2 diabetes cases in each of the ethnic groups studied. However, the variation in insulin resistance and type 2 diabetes risk between Asian subgroups is not consistently explained by adiposity, indicating an important role for additional mechanisms underlying the susceptibility to cardiometabolic disease in Asian populations. FUNDING: Nanyang Technological University-the Lee Kong Chian School of Medicine, National Healthcare Group, and National Medical Research Council, Singapore.
引用
- Mina T, Xie W, Low DY, et al. Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore. Lancet Diabetes Endocrinol. 2024. PMID: 39217997. doi:10.1016/S2213-8587(24)00195-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。